Navigation Links
With Early-Stage Prostate Cancer Treatment, Older Men Live Longer

“Watch and Wait” – a usual statement – often recommended by the doctors to the older patients with early stages of Prostate Cancer. But now a new study by researchers at Fox// Chase Cancer Center and University of Pennsylvania finds that older men with early-stage prostate cancer live longer if the disease is treated with radiation or surgery instead of simply waiting and watching.

Researchers have found that patients (aged 65 to 80) who were treated had more than 30% lower risk of death during the 12 years they were tracked than those who did nothing. Prostate Cancer is the most common cancer affecting most of the men in United States and increasing number of cases are being diagnosed as it can be easily detected by a blood test.

The study results were based on the medical records of more than 44,000 men, who were diagnosed with the disease between 1991 and 1999 and who had survived more than a year past diagnosis. The study ended at the end of 2002. The results were published in the latest issue of the Journal of the American Medical Association. However the report added that: “These results must be validated by rigorous randomized controlled trials of elderly men with localized prostate cancer before the findings can be used to inform treatment decisions.”

Mark Litwin and David Miller, two physicians at University of California, Los Angeles, noted that the findings of this study are preliminary, while commenting on the study in an editorial of the same issue.

They also advised that Doctors must remain steadfast in their efforts to reduce over-treatment and under-treatment by thoughtfully defining each patient's unique balance between the natural history of prostate cancer and that individual patient's life expectancy.

'"/>




Page: 1

Related medicine news :

1. New Test For Early-Stage Lung Cancer
2. Cancer Doctors Okays Controversial Prostate Therapy
3. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
4. New Prostate Cancer Vaccine Shows Promise
5. Hormone Therapy applicable for Prostate Cancer
6. Prostate cancer and Vitamins
7. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
8. Early Detection Of Prostate Cancer
9. Awareness increase Prostate cancer detection
10. Better Prostate Cancer Test
11. Stopping Prostate Cancer from Spreading
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol ... is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex ... in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement earlier this ... The former overall number one pick in the 2001 NFL Draft, to the Atlanta ... record for the most career rushing yards by a quarterback (6,109) and the most ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner ... Education Research Award. The award honors scholars exemplary in their capacity to communicate ... who has demonstrated the capacity to deepen the public’s understanding and appreciation of ...
(Date:4/24/2017)... ... April 24, 2017 , ... Sean Fay is the undisputed ... Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which sold more than 100 ... in the last 25 years. , Now, due to changes in the broadcast media ...
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class designers ... to bring their novel lifesaving device for the everyday use of parents worldwide. ... specially designed to read a child’s vital signs, and detect unusual symptoms or ...
Breaking Medicine News(10 mins):
(Date:4/21/2017)... 2017 Halo Labs announces the launch of ... system called the Horizon at PEGS 2017 in ... system analyzes sub visible particulate matter in biopharmaceutical samples ... as early as candidate selection and pre-formulation. ... research organization Elion Labs for system validation. ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
Breaking Medicine Technology: